Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/27/2002EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002EP1259493A2 Substituted piperazine compounds
11/27/2002EP1259492A1 Substituted piperazine derivatives as mtp inhibitors
11/27/2002EP1259491A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates and amides and their use as alpha-1a agonists
11/27/2002EP1259490A2 Synthesis of epothilones, intermediates thereto and analogues thereof
11/27/2002EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002EP1259487A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
11/27/2002EP1259485A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/27/2002EP1259484A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
11/27/2002EP1259482A2 Sulfur containing compounds
11/27/2002EP1259481A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
11/27/2002EP1259477A1 Aminoadamantane derivatives as therapeutic agents
11/27/2002EP1259474A1 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
11/27/2002EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002EP1259292A2 Therapeutic agents
11/27/2002EP1259264A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
11/27/2002EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002EP1259261A1 Pharmaceutical compositions comprising terbinafine
11/27/2002EP1259260A1 Combination therapy for the treatment of inflammatory and respiratory diseases
11/27/2002EP1259246A2 Use of dpp-iv inhibitors for the treatment of diabetes
11/27/2002EP1259245A2 Novel compositions and uses of dictyostatin compounds
11/27/2002EP1259244A1 Veterinary compositions for the treatment of parasitic diseases
11/27/2002EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/27/2002EP1259242A2 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
11/27/2002EP1259241A1 The use of scopolamine salts
11/27/2002EP1259240A2 Agents, such as nicotinamide or cadpr for the treatment of skin disorders
11/27/2002EP1259239A2 Use of cox-2 inhibitors as gastroprokinetics
11/27/2002EP1259238A1 Stable acid labile benzimidazole pharmaceutical compositions
11/27/2002EP1259237A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/27/2002EP1259236A1 Tyrosine kinase inhibitors
11/27/2002EP1259235A1 Tyrosine kinase inhibitors
11/27/2002EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002EP1259233A1 Modulation of bone formation
11/27/2002EP1259231A2 Naphthoquinone derivatives as cd45 inhibitors
11/27/2002EP1259230A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
11/27/2002EP1259229A2 Use of pde v inhibitors
11/27/2002EP1259226A2 Anaesthetic formulations
11/27/2002EP1259225A2 Liposomes
11/27/2002EP1259224A2 Cochleate formulations and their use for delivering biologically relevant molecules
11/27/2002EP1259218A2 Cosmetic composition for the treatment of skin ageing and/or stressed skin
11/27/2002EP1259125A1 Inulin products with improved nutritional properties
11/27/2002EP1259121A2 Weight loss induced by reduction in neuropeptide y level
11/27/2002EP1259112A1 Nutritional intervention composition for enhancing and extending satiety
11/27/2002EP1192152B1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
11/27/2002EP1114024B1 Urokinase inhibitors
11/27/2002EP1112005B1 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid
11/27/2002EP1109557B1 Use of cetirizine for preventing the onset of asthma
11/27/2002EP1107795B1 Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
11/27/2002EP1093369B1 Agent with an antidepressive effect comprising pramipexole and sertraline
11/27/2002EP1089744B1 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin
11/27/2002EP1089742B1 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
11/27/2002EP1083929A4 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
11/27/2002EP1073639B1 Quinoline derivatives
11/27/2002EP1018338B1 Use of a retinoid type compound to increase in vivo the decoupling activity of the protein ucp2
11/27/2002EP1017672B1 New npy antagonists
11/27/2002EP1001934B1 Indole compounds as cox-2 inhibitors
11/27/2002EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002EP0998480B1 Nucleotide analog composition and synthesis method
11/27/2002EP0996430B1 Nucleotide analog compositions
11/27/2002EP0994887B1 Modified glycosides, compositions comprised thereof and methods of use thereof
11/27/2002EP0991741B1 WAX ESTERS ENRICHED IN $g(v)-3 UNSATURATED FATTY ACIDS, THEIR PREPARATION AND THEIR USE
11/27/2002EP0984915A4 Lutein esters having high bioavailability
11/27/2002EP0977564A4 Forskohlin for promoting lean body mass
11/27/2002EP0975223A4 In-situ generation of zinc pyrithione
11/27/2002EP0960110B8 3-ARYL SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF1) SPECIFIC LIGANDS
11/27/2002EP0934331B1 Mirror-symmetrical selection and evolution of nucleic acids
11/27/2002EP0929547B1 Benzamidine derivatives substituted by cyclic amino acid or cycl ic hydroxy acid derivatives and their use as anti-coagulants
11/27/2002EP0915093B1 Amide derivatives
11/27/2002EP0912554B1 Indoline derivatives useful as 5-ht-2c receptor antagonists
11/27/2002EP0910360B1 Reduction of cardiotoxicity of an antitumor agent using manganese compound
11/27/2002EP0862557B1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
11/27/2002EP0857064B1 Stabilised pharmaceutical preparations containing thyroid hormone
11/27/2002EP0854707B1 Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt
11/27/2002EP0814782B1 Pharmaceutical composition stabilized with a basic agent
11/27/2002EP0783303B1 Use of aromatic halides for treating mammalian cell proliferation
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002EP0776204B1 Indole alkaloids useful as anti-inflammatory agents
11/27/2002EP0765330B1 Lactam inhibitors of cholesterol esterase
11/27/2002EP0708648B1 Inhibition of nitric oxide production by retinoic acid
11/27/2002EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002EP0671928B1 Synthesis of n-substituted oligomers
11/27/2002EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002CN1382206A Color safe laundry methods employing zwitterionic formulation components
11/27/2002CN1382158A Multiple cytokine-antibody complexes
11/27/2002CN1382152A Novel A-500359 derivatives
11/27/2002CN1382151A Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols
11/27/2002CN1382150A Hydromycin derivatives
11/27/2002CN1382149A Hygromycin A prodrugs
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382145A Remedies for neuropathic pain and model animals of neuropathic pain
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382142A Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382141A 1,8-naphthyridine derivatives
11/27/2002CN1382140A Neurotrophic pyrrolidines and piperidines and related compositions containing them
11/27/2002CN1382139A Method and intermediate for preparing is-a-oxazole formylamine and its analogue
1 ... 5639 5640 5641 5642 5643 5644 5645 5646 5647 5648 5649 5650 5651 5652 5653 5654 5655 5656 5657 5658 5659 ... 7860